FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077356371> ?p ?o ?g. }

• W2077356371 endingPage "1718" @default.
• W2077356371 startingPage "1711" @default.
• W2077356371 abstract "CP-690 550 inhibits Janus kinase 3 with nanomolar potency. In this dose-escalation study, we assessed the safety, tolerability, effects on lymphocyte subsets, and pharmacokinetics of CP-690 550 when coadministered with mycophenolate mofetil in stable renal allograft recipients for 28 days. Twenty-eight patients were enrolled. Six patients received CP-690 550 5 mg twice daily (BID), 6 patients received 15 mg BID, 10 patients received 30 mg BID, and 6 patients received placebo. The most frequent adverse events were infections and gastrointestinal (abdominal pain, diarrhea, dyspepsia, and vomiting). CP-690 550 15 mg BID and 30 mg BID were associated with a mean decrease in hemoglobin from baseline of 11% and a mean decrease in absolute natural killer cell counts of 50%. CP-690 550 30 mg BID was also associated with a mean increase in absolute CD19(+) B-lymphocytes of 130%. There were no changes in the number of neutrophils, total lymphocytes, platelets, or CD4(+) or CD8(+) T cells; clinical chemistry; vital signs; or electrocardiograms from the pretreatment baseline. Administration of CP-690 550 without a concomitant calcineurin inhibitor resulted in CP-690 550 exposures consistent with previous studies in nontransplant subjects. Additional dose-ranging studies are warranted to evaluate the safety and efficacy of CP-690 550 in renal transplant recipients over longer treatment duration." @default.
• W2077356371 created "2016-06-24" @default.
• W2077356371 creator A5000747220 @default.
• W2077356371 creator A5011538150 @default.
• W2077356371 creator A5011738198 @default.
• W2077356371 creator A5017765749 @default.
• W2077356371 creator A5031466675 @default.
• W2077356371 creator A5040976474 @default.
• W2077356371 creator A5042236941 @default.
• W2077356371 creator A5051124193 @default.
• W2077356371 creator A5053704561 @default.
• W2077356371 creator A5055451309 @default.
• W2077356371 creator A5060132287 @default.
• W2077356371 creator A5071829945 @default.
• W2077356371 creator A5074755563 @default.
• W2077356371 date "2008-08-01" @default.
• W2077356371 modified "2023-10-03" @default.
• W2077356371 title "Phase 1 Dose-Escalation Study of CP-690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics" @default.
• W2077356371 cites W1996393914 @default.
• W2077356371 cites W2005635080 @default.
• W2077356371 cites W2046710165 @default.
• W2077356371 cites W2068788965 @default.
• W2077356371 cites W2070029350 @default.
• W2077356371 cites W2073058639 @default.
• W2077356371 cites W2083018406 @default.
• W2077356371 cites W2093804554 @default.
• W2077356371 cites W2117926449 @default.
• W2077356371 cites W2141836626 @default.
• W2077356371 cites W2154974848 @default.
• W2077356371 cites W4235213462 @default.
• W2077356371 doi "https://doi.org/10.1111/j.1600-6143.2008.02307.x" @default.
• W2077356371 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18557720" @default.
• W2077356371 hasPublicationYear "2008" @default.
• W2077356371 type Work @default.
• W2077356371 sameAs 2077356371 @default.
• W2077356371 citedByCount "72" @default.
• W2077356371 countsByYear W20773563712012 @default.
• W2077356371 countsByYear W20773563712013 @default.
• W2077356371 countsByYear W20773563712014 @default.
• W2077356371 countsByYear W20773563712015 @default.
• W2077356371 countsByYear W20773563712016 @default.
• W2077356371 countsByYear W20773563712017 @default.
• W2077356371 countsByYear W20773563712018 @default.
• W2077356371 countsByYear W20773563712019 @default.
• W2077356371 countsByYear W20773563712021 @default.
• W2077356371 countsByYear W20773563712022 @default.
• W2077356371 countsByYear W20773563712023 @default.
• W2077356371 crossrefType "journal-article" @default.
• W2077356371 hasAuthorship W2077356371A5000747220 @default.
• W2077356371 hasAuthorship W2077356371A5011538150 @default.
• W2077356371 hasAuthorship W2077356371A5011738198 @default.
• W2077356371 hasAuthorship W2077356371A5017765749 @default.
• W2077356371 hasAuthorship W2077356371A5031466675 @default.
• W2077356371 hasAuthorship W2077356371A5040976474 @default.
• W2077356371 hasAuthorship W2077356371A5042236941 @default.
• W2077356371 hasAuthorship W2077356371A5051124193 @default.
• W2077356371 hasAuthorship W2077356371A5053704561 @default.
• W2077356371 hasAuthorship W2077356371A5055451309 @default.
• W2077356371 hasAuthorship W2077356371A5060132287 @default.
• W2077356371 hasAuthorship W2077356371A5071829945 @default.
• W2077356371 hasAuthorship W2077356371A5074755563 @default.
• W2077356371 hasBestOaLocation W20773563711 @default.
• W2077356371 hasConcept C112705442 @default.
• W2077356371 hasConcept C126322002 @default.
• W2077356371 hasConcept C142724271 @default.
• W2077356371 hasConcept C197934379 @default.
• W2077356371 hasConcept C204787440 @default.
• W2077356371 hasConcept C27081682 @default.
• W2077356371 hasConcept C2778375690 @default.
• W2077356371 hasConcept C71924100 @default.
• W2077356371 hasConcept C90924648 @default.
• W2077356371 hasConcept C98274493 @default.
• W2077356371 hasConceptScore W2077356371C112705442 @default.
• W2077356371 hasConceptScore W2077356371C126322002 @default.
• W2077356371 hasConceptScore W2077356371C142724271 @default.
• W2077356371 hasConceptScore W2077356371C197934379 @default.
• W2077356371 hasConceptScore W2077356371C204787440 @default.
• W2077356371 hasConceptScore W2077356371C27081682 @default.
• W2077356371 hasConceptScore W2077356371C2778375690 @default.
• W2077356371 hasConceptScore W2077356371C71924100 @default.
• W2077356371 hasConceptScore W2077356371C90924648 @default.
• W2077356371 hasConceptScore W2077356371C98274493 @default.
• W2077356371 hasIssue "8" @default.
• W2077356371 hasLocation W20773563711 @default.
• W2077356371 hasLocation W20773563712 @default.
• W2077356371 hasOpenAccess W2077356371 @default.
• W2077356371 hasPrimaryLocation W20773563711 @default.
• W2077356371 hasRelatedWork W1830687917 @default.
• W2077356371 hasRelatedWork W1966047811 @default.
• W2077356371 hasRelatedWork W2003042623 @default.
• W2077356371 hasRelatedWork W202460821 @default.
• W2077356371 hasRelatedWork W2068849886 @default.
• W2077356371 hasRelatedWork W2074207917 @default.
• W2077356371 hasRelatedWork W2147606462 @default.
• W2077356371 hasRelatedWork W4205587618 @default.
• W2077356371 hasRelatedWork W4296087748 @default.
• W2077356371 hasRelatedWork W4366822339 @default.
• W2077356371 hasVolume "8" @default.

• next